BrCa is a heterogeneous disease with diverse pathogenesis, which is mainly classified into four molecular subtypes, characterized by the expression of Estrogen Receptor (ERα), Progesterone receptor (PR) and the Epidermal Growth Factor Receptor (EGFR) family member Her2 [2]. This evidence concerns the gene EGFR and invasive breast carcinoma.